51
TITLE: Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
AUTHORS: Lobo Martins, S; Ferreira, AR; Mansinho, A; Casimiro, S; Leitzel, K; Ali, S; Lipton, A; Costa, L;
PUBLISHED: 2020, SOURCE: CANCERS, VOLUME: 12, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
52
TITLE: Bone metastases
AUTHORS: Coleman, RE; Croucher, PI; Padhani, AR; Clézardin, P; Chow, E; Fallon, M; Guise, T; Colangeli, S; Capanna, R; Costa, L;
PUBLISHED: 2020, SOURCE: Nature Reviews Disease Primers, VOLUME: 6, ISSUE: 1
INDEXED IN: Scopus CrossRef: 268
IN MY: ORCID
53
TITLE: The antibacterial and angiogenic effect of magnesium oxide in a hydroxyapatite bone substitute  Full Text
AUTHORS: Coelho, CC; Padrao, T; Costa, L; Pinto, MT; Costa, PC ; Domingues, VF ; Quadros, PA; Monteiro, FJ ; Sousa, SR ;
PUBLISHED: 2020, SOURCE: SCIENTIFIC REPORTS, VOLUME: 10, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 1
54
TITLE: Modelling cancer outcomes of bone metastatic patients: combining survival data with N-Telopeptide of type I collagen (NTX) dynamics through joint models  Full Text
AUTHORS: Loureiro, H; Carrasquinha, E; Alho, I; Ferreira, AR; Costa, L; Carvalho, AM ; Vinga, S ;
PUBLISHED: 2019, SOURCE: BMC MEDICAL INFORMATICS AND DECISION MAKING, VOLUME: 19, ISSUE: 1
INDEXED IN: WOS CrossRef: 3
IN MY: ORCID
55
TITLE: Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer-induced bone loss
AUTHORS: Dionísio, MR; Mansinho, A; Abreu, C; Cavaco Silva, J; Casimiro, S; Costa, L;
PUBLISHED: 2019, SOURCE: British Journal of Clinical Pharmacology, VOLUME: 85, ISSUE: 6
INDEXED IN: Scopus CrossRef: 21
IN MY: ORCID
56
TITLE: Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody
AUTHORS: von Moos, R; Costa, L; Gonzalez Suarez, E; Terpos, E; Niepel, D; Body, JJ;
PUBLISHED: 2019, SOURCE: CANCER TREATMENT REVIEWS, VOLUME: 76
INDEXED IN: Scopus WOS CrossRef: 98
IN MY: ORCID
57
TITLE: Ribociclib induces macrocytosis in therapeutic doses: characterization of outcome  Full Text
AUTHORS: Alves, S; Costa, L; Mansinho, A; Dionisio, MR; Andrade, P;
PUBLISHED: 2019, SOURCE: 14th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics (EACPT) in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 75
INDEXED IN: WOS
58
TITLE: Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues
AUTHORS: Gil Marques, F; Poli, E; Malaquias, J; Carvalho, T; Portêlo, A; Ramires, A; Aldeia, F; Ribeiro, RM; Vitorino, E; Diegues, I; Costa, L; Coutinho, J; Pina, F; Mareel, M; Constantino Rosa Santos, S;
PUBLISHED: 2019, SOURCE: Radiotherapy and Oncology, VOLUME: 141
INDEXED IN: Scopus CrossRef: 12
IN MY: ORCID
59
TITLE: Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study
AUTHORS: Ferreira, AR; Ribeiro, J; Miranda, A; Mayer, A; Passos Coelho, JL; Brito, M; Fernandes, J; Gouveia, J; Costa, L; Vaz Luis, I;
PUBLISHED: 2019, SOURCE: CLINICAL BREAST CANCER, VOLUME: 19, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 3
IN MY: ORCID
60
TITLE: Impact of the metastatic compartment on bone biomarkers and bone outcomes in patients (pts) with breast cancer (BC) and bone metastases (BM) in trial NCT00321464 of denosumab vs. zoledronic acid
AUTHORS: Ferreira, AR; Casimiro, S; Ali, S; Leitzel, K; Lipton, A; Costa, L;
PUBLISHED: 2019, SOURCE: San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 79, ISSUE: 4
INDEXED IN: WOS CrossRef
Page 6 of 17. Total results: 164.